Magri, M D Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee. [electronic resource] - Tumori Feb 1991 - 49-51 p. digital Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't ISSN: 0300-8916 Standard No.: 10.1177/030089169107700112 doi Subjects--Topical Terms: AgedDrug EvaluationEpirubicin--therapeutic useFemaleHumansLung Neoplasms--drug therapyMaleMesothelioma--drug therapyMiddle Aged